Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $904000.0.

  • Xtant Medical Holdings' Interest Expenses fell 2460.38% to $904000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 632.15%. This contributed to the annual value of $4.2 million for FY2024, which is 4159.29% up from last year.
  • Xtant Medical Holdings' Interest Expenses amounted to $904000.0 in Q3 2025, which was down 2460.38% from $1.0 million recorded in Q2 2025.
  • Xtant Medical Holdings' Interest Expenses' 5-year high stood at $1.2 million during Q3 2024, with a 5-year trough of $1000.0 in Q1 2021.
  • Its 5-year average for Interest Expenses is $670421.1, with a median of $760000.0 in 2023.
  • Its Interest Expenses has fluctuated over the past 5 years, first plummeted by 9990.97% in 2021, then skyrocketed by 3580000.0% in 2022.
  • Over the past 5 years, Xtant Medical Holdings' Interest Expenses (Quarter) stood at $466000.0 in 2021, then rose by 6.22% to $495000.0 in 2022, then skyrocketed by 65.25% to $818000.0 in 2023, then surged by 38.63% to $1.1 million in 2024, then decreased by 20.28% to $904000.0 in 2025.
  • Its Interest Expenses stands at $904000.0 for Q3 2025, versus $1.0 million for Q2 2025 and $1.0 million for Q1 2025.